Evidence map›Paper›PMID 35369469›Full record

ArticleFrontiers in microbiology2022

Carbapenemase-Producing Extraintestinal Pathogenic

María Belén Sanz, Denise De Belder, J M de Mendieta, Diego Faccone, Tomás Poklepovich, Celeste Lucero, Melina Rapoport, Josefina Campos, Ezequiel Tuduri, Mathew O Saavedra and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Detection of polymyxin-resistant Enterobacteriaceae from poultry farms in Brazil: continued mcr gene dissemination.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Article
  3. Article
  4. Sporadic cloneFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

María Belén SanzServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Denise De BelderServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
J M de MendietaServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Diego FacconeServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Tomás PoklepovichPlataforma Genómica y Bioinformática (PLABIO), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Celeste LuceroServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Melina RapoportServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Josefina CamposPlataforma Genómica y Bioinformática (PLABIO), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Ezequiel TuduriServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Mathew O SaavedraDepartment of Pathology and Genomic Medicine, Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Hospital, Houston Methodist Research Institute, Houston, TX, United States.
Claudia Van der PloegServicio de Antígenos y Antisueros, INPB-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Ariel RogéServicio de Antígenos y Antisueros, INPB-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Carbapenemases-ExPEC Group
Fernando PasteranServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Alejandra CorsoServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Adriana E RosatoDepartment of Pathology and Molecular Microbiology Diagnostics-Research, Riverside University Health System, Moreno Valley, CA, United States.
Sonia A GomezServicio Antimicrobianos, Laboratorio Nacional de Referencia en Resistencia a los Antimicrobianos (LNRRA), INEI-ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Administración Nacional de Laboratorios e Institutos de Salud · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARHouston Methodist · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extraintestinal pathogenic

Indexed as

carbapenemaseEscherichia coliExPEChigh risk clonephylogeny

Identifiers

PMID35369469
PMCPMC8971848
OpenAlexW4220716554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.